RH+N-KLINIKUM Aktiengesellschaft Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was EUR 711.19 million compared to EUR 682.8 million a year ago. Revenue was EUR 817.63 million compared to EUR 777.58 million a year ago. Net income was EUR 11.52 million compared to EUR 8.06 million a year ago. Basic earnings per share from continuing operations was EUR 0.17 compared to EUR 0.12 a year ago. Diluted earnings per share from continuing operations was EUR 0.17 compared to EUR 0.12 a year ago.